← All trials
NCT01474681
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 9, 2012
- Primary completion
- Oct 3, 2016
- Completion date
- Oct 3, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 27
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
Drugs studied
Indications studied
- Burkitt Lymphoma
- Lymphoma
- Lymphoma, Follicular
- Lymphoma, Non-Hodgkin
- Myelodysplastic Syndromes
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid, Acute
- Lymphoma, Large-Cell, Immunoblastic
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Mantle-Cell
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.